Background: Radiation exposure is associated with increased risk of malignancies and cataract formation. Recent case series of predominantly left sided brain malignancies in interventional cardiologists suggest an increased risk with long term exposure to occupational radiation. These data suggest that further measures to protect healthcare workers are needed. We aimed to evaluate the efficacy of two novel shields in reducing interventional cardiologists' radiation exposure during angiographic procedures. Methods: We conducted a prospective, randomized, controlled clinical trial with enrollment of 230 patients undergoing coronary angiography or percutaneous coronary intervention from November 2013 to May 2014. Patients were randomized to have their procedure performed with or without placement of a pelvic lead shield designed for either radial or femoral access, and designed to reduce radiation scatter. During all procedures, an interventional cardiologist was fitted with a novel, paper thin, non-lead surgical cap (No Brainer, RADPAD, weight 53 grams) to protect the brain from radiation exposure. The co-primary outcomes for the lead shield comparison was i) the difference between both groups in total operator radiation dose (mSv) at the left chest level and ii) the difference between groups in operator dose divided by Air Kerma (mSv/mGy). For the cap comparison, the primary outcome was the difference between total radiation dose (mSv) as measured by two dosimeters at left temporal region of the head of the interventional cardiologist (one on the outside of the cap and the other one on the inside of it). Radiation dose was measured using Unfors Educational Direct Dosimeters (EDD-30). Results: The full results of the study will be available at time of presentation. Conclusions: The RADIATION PROTECT study will help determine the efficacy of a novel lead shield and a novel non-lead surgical cap for reducing operator radiation exposure during coronary angiography or intervention.
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Patient And Occupational Dose Reduction Enabled By A Novel X-ray Imaging Technology For Interventional Cardiology: First Results
Liesbeth Eloot 1 , Klaus Bacher 1 , Thomas Gijs 1 , Emma Vanhalst 1 1 Ghent University, Ghent, Belgium Background: During interventional cardiology procedures patient and staff are exposed to X-ray radiation. Minimizing radiation dose is a crucial part of quality care. This study quantifies the radiation dose reduction for patient and staff enabled by a novel X-ray imaging technology using advanced real-time image noise reduction algorithms and an optimized acquisition chain (AlluraClarity, Philips Healthcare, The Netherlands). First results are reported. Methods: Between March-May 2014, 48 patients referred for coronary angiography and angioplasty were prospectively scheduled and randomized for room A (FD10 monoplane system with state of the art image processing and reference acquisition chain) or room B (FD2010 biplane system with the novel imaging technology) in a 1:2 ratio. Patients' demographics and procedure characteristics were recorded; exposure parameters from all planes were logged via DICOM SR. Scatter dose is quantified by a dosimeter placed on the C-arc, at a fixed position, not affected by any shielding device. Occupational dose is quantified by dosimeters placed on the torso and leg of physicians and logged via DICOM SR (DoseAware Xtend, Philips Healthcare, Best, The Netherlands). Results: Demographic data, exposure parameters and occupational doses are summarized in Table 1 , showing comparable patient demographics and procedure complexity for room A and B. DAP values for fluoroscopy and exposure decreased with 33% and 75%, respectively. Scatter dose decreased with 67% in room B for the C-arc dosimeter and 53% for the physician leg. However, physician torso dose (less than 35% of leg dose) did not differ significantly. This needs to be further investigated.
Conclusions:
The novel X-ray imaging technology resulted in a significant and substantial patient and occupational dose reduction, without affecting patient and procedure characteristics.
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Patient radiation exposure with a novel X-ray imaging technology during coronary angiography and angioplasty Fernando Cura 1 , Bonvini Victor 2 , Pablo Lamelas 3 , Gustavo O. Pedernera 4 , Pablo Spaletra 5 , Gerardo Nau 1 , Lucio T. Padilla 3 , Alfonsina Candiello 6 , Jorge Belardi 2 1 Instituto Cardiovascular de Buenos Aires, Buenos Aires, Buenos Aires, 2 Instituto Cardiovascular de Buenos Aires, Buenos Aires, Argentina, 3 ICBA, Buenos Aires, Argentina, 4 ICBA, BsAs, BsAs, 5 ICBA, Bs As, Bs As, 6 ICBA, Buenos Aires, Buenos Aires Background: A novel X-ray imaging technology (AlluraClarity, Philips Healthcare, Best, The Netherlands) enables patient radiation dose reduction by a combination of advanced image noise reduction algorithms with state-of-the-art hardware and an anatomy-specific optimized full acquisition chain. The main purpose of this analysis is to quantify patient radiation exposure during coronary angiography and intervention in real life using the novel ClarityIQ technology. Methods: Retrospective data was collected for the entire cohort of patients admitted for coronary interventions with the Allura Xper or AlluraClarity in our institution during the period November 2013 to March 2014. Patients were allocated to each equipment according to availability, unrelated to patient's characteristics and conditions. The primary endpoint was overall procedural patient dose, expressed in air kerma and dose area product (DAP). Results: The analysis comprised 1215 consecutive patients undergoing coronary diagnostic and therapeutic interventions, 532 (44 %) performed with AlluraClarity and 683 (56 %) with the Allura Xper. Clinical characteristics were similar among both groups, including BMI and weight. Air Kerma in the Allura Xper and AlluraClarity group were 930 mGy (IQR 517-1686) and 591 mGy (IQR 319-1173), respectively (37% reduction with Clarity, 95%CI 32 to 42%; p < 0,0001). DAP in the Xper and Clarity group were 98959 mGy/cm2 (IQR 52944-174757) and 59042 Gy/cm2 (IQR 32382.5-106784.5), respectively (41% reduction with Clarity, 95%CI 36 to 46%; p < 0,0001). Same radiation exposure reduction with Kerma and DAP were detected adjusting by radiation time. No significant differences were detected on radiation time (8.4 vs 9.2 minutes; p ¼ 0,58) or contrast used adjusted by radiation time (13,6 vs 13,20 mL/min; p ¼ 0,32) in the Xper and Clarity group, respectively. Conclusions: A profound reduction in procedural patient radiation exposure was measured by comparing the AlluraClarity with the Allura Xper equipment for patients undergoing coronary interventions with no impact in the radiation time and contrast use. Reduction of patient and operator radiation exposure is one of the most important challenges of modern cathlabs. Methods: This is a single center registry report of all consecutive robotic assisted PCI procedures performed with the CorPath 200. Results: We enrolled 19 patients (mean age 68;74% male) and demonstrate that 52% of the cases performed were for type C lesions, with 16 of 19 cases performed entirely robotically or with minimal manual manipulation. Procedural and clinical success for the series and contrast/fluoroscopy time used for the group are reported. Conclusions: The CorPath 200 robotic system can be used to treat complex coronary lesions including type C lesions, saphenous vein graft lesions, chronic total occlusions, multilesion or multivessel disease, and with arterial access obtained via the radial approach. 
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